Skip to main content

Table 1 Clinical and laboratory characteristics of 101 AEG patients associated with OS

From: Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction

Patient-related factors

No. of patients (%)

OS (months) [mean (95 % CI)]

P values

Gender

 Male

80 (79.2)

42.3 (36.9–47.7)

0.343

 Female

21 (20.8)

48.5 (39.4–57.7)

 

Age (years)

 <60

23 (22.8)

44.5 (34.9–54.1)

0.976

 ≥60

78 (77.2)

43.3 (38.9–48.3)

 

BMI (kg/m2)

 <18.5

9 (8.9)

31.7 (18.8–14.6)

0.180

 ≥18.5 and <25

71 (70.3)

45.5 (40.0–51.1)

 

 ≥25

21 (20.8)

41.4 (30.7–52.0)

 

Hemoglobin (g/L)

 <120

41 (40.6)

38.4 (31.4–45.4)

0.029*

 ≥120

60 (59.4)

44.6 (41.0–53.4)

 

Albumin (g/L)

 <40

27 (26.7)

35.7 (26.4–44.9)

0.036*

 ≥40

74 (73.3)

46.0 (38.9–48.3)

 

Pre-albumin (g/L)

 <200

29 (28.7)

31.5 (23.6–39.3)

<0.001*

 ≥200

72 (71.3)

48.0 (43.0–53.8)

 

PNI

 <51

54 (53.5)

37.6 (31.0–44.2)

0.008*

 ≥51

47 (46.5)

50.5 (44.3–56.7)

 

Tumor size (cm)

  

0.004*

 <5

64 (63.4)

48.3 (42.5–54.1)

 

 ≥5

37 (36.6)

35.4 (28.0–42.8)

 

Differentiation grade

 Poor

69 (68.3)

39.4 (33.5–45.3)

0.031*

 Well

32 (31.7)

52.0 (45.0–58.0)

 

Tumor location

 Siewert II

6 (5.9)

40.3 (19.6–61.1)

0.923

 Siewert III

95 (5.1)

43.8 (38.9–48.6)

 

T stage

 T1, T2

18 (17.8)

61.9 (56.2–67.6)

0.001*

 T3, T4

83 (82.2)

39.6 (34.4–44.9)

 

N stage

 N0

41 (40.6)

51.1 (43.9–58.4)

0.001*

 N1

43 (42.6)

41.3 (34.7–47.9)

 

 N2

16 (15.8)

32.5 (20.8–44.2)

 

 N3

1 (1.0)

8.0 (8.0–8.0)

 

TNM stage

 I, II

44 (43.6)

52.5 (45.7–59.2)

<0.001*

 III, IV

57 (56.4)

36.7 (30.8–42.7)

 

Surgical type

 Total gastrectomy

6 (5.9)

57.0 (42.7–71.3)

0.131

 Proximal gastrectomy

95 (94.1)

42.7 (37.8–47.6)

 
  1. BMI body mass index, PNI prognostic nutritional index
  2. *P < 0.05